首页   >  
Angiogenesis/Protein Tyrosine Kinase
  >  
Insulin Receptor

所有产品分类

所有产品

信号通路

研究领域

天然产物

抗体

多肽

催化剂

杂质对照品

医药中间体

基础原料

Insulin Receptor

结构式 货号 产品名称 CAS号
MID-1 结构式
 BCP48931 MID-1 312608-54-1
MID-1 is an inhibitor of MG53-IRS-1 (Mitsugumin 53-Insulin Receptor Substrate-1) interaction.
SU4984 结构式
 BCP44116 SU4984 186610-89-9
SU4984 is a cell-permeable, reversible, and ATP-competitive inhibitor of the tyrosine kinase activity of fibroblast growth factor receptor 1 (FGFR1; IC50 = 10-20 µM).
NBI-31772 结构式
 BCP42327 NBI-31772 374620-70-9
NBI-31772 is an potent insulin-like growth factor-1 binding protein (IGFBP) inhibitor.
Insulin 结构式
 BCP37517 胰岛素 12584-58-6
KU14R 结构式
 BCP06499 KU14R 189224-48-4
A new I(3)-R antagonist, KU14R (2 (2-ethyl 2,3-dihydro-2-benzofuranyl)-2-imidazole), which selectively blocks the insulin secretory response to imidazolines.
GSK1838705A 结构式
 BCP02847 GSK1838705A 1116235-97-2
GSK1838705A is a potent small-molecule IGF-IR, the insulin receptor and anaplastic lymphoma kinase (ALK) inhibitor with IC50 of 2.0, 1.6 and 0.5 nM, respectively.
NVP-AEW541 结构式
 BCP02417 NVP-AEW541 475489-16-8
NVP-AEW541 is an IGF-IR inhibitor with an IC50 of median 3.6 μM.
BMS-754807 结构式
 BCP01926 BMS-754807 1001350-96-4
BMS-754807 is an orally bioavailable antagonist of human insulin-like growth factor type I receptor (IGF-1R) with potential antineoplastic activity.
Linsitinib 结构式
 BCP01831 Linsitinib 867160-71-2
Linsitinib is highly potent, orally efficacious and highly selective, dual ATP-competitive tyrosine kinase inhibitor of insulin-like growth factor-1 receptor (IGF-1R) (IC50: 35 nM) and insulin receptor (IR) (IC50: 75 nM).
Insulin degludec 结构式
 BCP23700 德谷胰岛素 844439-96-9
Insulin degludec is an Insulin Analog. The chemical classification of insulin degludec is Insulin.
12下一页共 15 条记录 1 / 2 页 
2853530910